BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9751109)

  • 21. [General and local hormonal therapy in scleroderma].
    Dobrescu A; Petrescu Z; Martinescu E; Costinescu M; Vasilca A; Popescu E; Rotaru L; Tăranu T; Pavelescu DM
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):145-9. PubMed ID: 3393746
    [No Abstract]   [Full Text] [Related]  

  • 22. [The course of scleroderma following treatment with carnitin].
    Nitzschner H
    Dermatol Monatsschr; 1974 Jul; 160(7):592-6. PubMed ID: 4411133
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
    Didenko IG
    Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249
    [No Abstract]   [Full Text] [Related]  

  • 24. Endothelial apoptosis in scleroderma: comment on the article by Black et al.
    Stefanec T
    Arthritis Rheum; 1999 Nov; 42(11):2491. PubMed ID: 10555046
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of tolerance induction in patients with suspected penicillin allergy--a case study.
    Wessbecher R; Stangl S
    Int J Dermatol; 2009 May; 48(5):488-91. PubMed ID: 19416379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of scleroderma].
    Holzmann H; Korting GW; Morsches B
    Actas Dermosifiliogr; 1971; 62(1):1-12. PubMed ID: 5158422
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of Tebessal in scleroderma].
    Mattos O; de Oliveira Neto MP
    Rev Bras Med; 1972 Mar; 29(3):139-40. PubMed ID: 5033154
    [No Abstract]   [Full Text] [Related]  

  • 28. Salazopyrin (azulfidine) treatment in scleroderma.
    Dover N
    Isr J Med Sci; 1971 Nov; 7(11):1301-3. PubMed ID: 4400695
    [No Abstract]   [Full Text] [Related]  

  • 29. [Trafuril reaction in scleroderma].
    Urban J
    Przegl Dermatol; 1976; (6 Suppl):367-9. PubMed ID: 1032188
    [No Abstract]   [Full Text] [Related]  

  • 30. [Complex treatment of different forms of scleroderma].
    Braĭtsev AV; Marzeeva GI
    Vestn Dermatol Venerol; 1974 Jun; 0(6):75-80. PubMed ID: 4423437
    [No Abstract]   [Full Text] [Related]  

  • 31. PUVA treatment in sclerodermatoid spectrum of dermatologic diseases: our initial experience.
    Baum S; Pavlotsky F; Shpiro D; Trau H
    Isr Med Assoc J; 2004 Sep; 6(9):563-4. PubMed ID: 15373320
    [No Abstract]   [Full Text] [Related]  

  • 32. [Initial results of high-dosage hyaluromidase long-term therapy ("Hylase" Dessau) in dermatology].
    Wozniak KD; Braun W
    Dtsch Gesundheitsw; 1972 Jun; 27(22):1046-8. PubMed ID: 4557763
    [No Abstract]   [Full Text] [Related]  

  • 33. [The prognosis and treatment of scleroderma].
    Degos R
    Rev Prat; 1975 May; 25(25):2003-4, 2005-7. PubMed ID: 1135588
    [No Abstract]   [Full Text] [Related]  

  • 34. Stimulating circulation to end stasis in scleroderma.
    Yuan X; Li JD; Chen WJ; Li ZS; Zhu HT; Liu JW; Zhu MJ
    Chin Med J (Engl); 1981 Feb; 94(2):85-93. PubMed ID: 6786844
    [No Abstract]   [Full Text] [Related]  

  • 35. Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes.
    Henrotin YE; Sanchez C; Deberg MA; Piccardi N; Guillou GB; Msika P; Reginster JY
    J Rheumatol; 2003 Aug; 30(8):1825-34. PubMed ID: 12913942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of systemic scleroderma with D-penicillin].
    Ivanova MM; Guseva NG; Balabanova RM; Oskilko TG
    Ter Arkh; 1977; 49(11):91-9. PubMed ID: 605409
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic effectiveness of treatment of patients with scleroderma at the Pyatigorsk Spa].
    Braĭtsev AV; Kessel' VP; Marzeeva GI; Shliapak EA; Angelova VS
    Vestn Dermatol Venerol; 1971 Oct; 45(10):35-9. PubMed ID: 5134075
    [No Abstract]   [Full Text] [Related]  

  • 38. [Low-molecular dextran (40,000) in the treatment of scleroderma].
    Szczepański A; Zielińska Z; Polkowska M; Lorenc B
    Przegl Dermatol; 1975; 62(1):79-82. PubMed ID: 1111035
    [No Abstract]   [Full Text] [Related]  

  • 39. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
    Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
    J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Conservative treatment of chronic lymphedema and sclerotic skin processes].
    Konopik J
    Z Arztl Fortbild (Jena); 1984; 78(8):307-10. PubMed ID: 6233797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.